News
Can Solana Reach $1,000?
Solana (CRYPTO: SOL) is one of the fastest-growing cryptocurrencies of the year. Its price has soared by nearly 15,000% since the beginning of the year, outpacing Ethereum (CRYPTO: ETH) (which is up
How Much Will Your Social Security Benefit Shrink by Claiming Early?
Thinking of starting your Social Security checks early? This is a common decision made by many retirees, but it's also a choice with lasting financial consequences that will follow you for the rest
Will Adagio's COVID Antibody Therapy Be Too Late to the Party?
Adagio Therapeutics (NASDAQ: ADGI) plans to file for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration for its COVID-19 antibody therapy in the second quarter of 2022. In
Better Chinese Tech Stock: Alibaba or Baidu
Alibaba (NYSE: BABA) and Baidu (NASDAQ: BIDU) are two of the largest tech companies in China. Alibaba owns the country's largest e-commerce marketplaces and its top cloud infrastructure platform
Is It Too Late To Buy Innovative Industrial Properties?
Innovative Industrial Properties (NYSE: IIPR) has a unique focus on owning marijuana grow houses. That said, the real estate investment trust (REIT) is up 60% over the past year, more than 400% over
You Can Retire a Millionaire on This 1 Investment
Does a $1 million nest egg sound nice for retirement? If it does, you're in good company. The reality is that many of your living costs might rise as you age, and it helps to kick off your senior
Will Costco Surprise Investors on Thursday?
Costco (NASDAQ: COST) has some high expectations to try to meet in just a few days. The warehouse retailer's stock has trounced the market in the weeks leading up to Thursday's earnings report
Here's Why AstraZeneca Stock Could Help Make You Rich
What are the three characteristics of a dividend stock that allow investors to build significant wealth over the long term? I would argue that those three attributes are a market-beating dividend
2 Questions to Ask Before Tackling a Roth IRA Conversion
Roth IRA conversions help you avoid taxes on your retirement withdrawals, but they can make your taxes a little more complicated this year. If you're not careful, you could wind up with a bigger
3 Incredible Value Stocks to Buy Before 2021 Is Over
It's been a wild year for investors. Markets have been volatile, cryptocurrencies and meme stocks have posted explosive gains, and winning high-risk plays will probably take center stage when
Is Roblox Stock a Buy Now?
Recent IPO Roblox (NYSE: RBLX) is one of the most interesting mobile gaming companies in the market, with a platform that is wildly popular with younger users. In this Fool Live video clip, recorded
Nervous About Market Volatility? 3 Safe Stocks to Buy Now
When the market is roaring higher, volatile upswings can be a lot of fun for investors. Not so much on the downside, as stocks tend to fall faster than they rise. That's exactly what's been
Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?
Moderna (NASDAQ: MRNA) and AstraZeneca (NASDAQ: AZN) compete against each other in some markets with their respective COVID-19 vaccines. However, the two companies are also partners. They recently
1 Green Flag for Moderna in 2022, and 1 Red Flag
The past two years have been incredible for Moderna (NASDAQ: MRNA) -- and its investors. Shares of the biotech company surged more than 430% in 2020. And they're heading for an increase of more than
This Trend-Setter's Stock Is Set to Crush the Reopening
Revolve Group (NYSE: RVLV) is a fashion retailer with a business plan that centers around social media influencers and live marketing events in an effort to target Millennial and Gen Z customers
Claiming Social Security Before Full Retirement Age? Answer These Questions First
One great thing about Social Security is that you get choices when it comes to claiming benefits. You're entitled to your full monthly benefit, based on your earnings history, once you reach full
5 Bold Predictions for the Stock Market in 2022
It's hard to believe, but 2022 is already less than a month away. Every December, I decide to have a little fun and come up with a list of five predictions for the stock market in the following year
2 Growth Stocks I'd Avoid in 2022
Buying on the dip (or crash, in some cases) can sometimes bring about great returns later on. But that's normally if a business is in solid shape to begin with and isn't down because of financial or
3 Investing Moves You Must Make Before the End of the Year
It's hard to believe that we're just a few weeks away from 2022. Most people are preparing for the holidays right about now, but that's not the only thing that should be on your mind. There are only
Does DeFi Put Your Portfolio at Risk?
As cryptocurrency prices continue to soar, decentralized finance (DeFi) is becoming more popular, as well.
DeFi is generally defined as the process of executing financial transactions without an
Here's My Top Cryptocurrency to Buy Before the New Year
It's that time of year -- time to make a list and check it twice. I'm not talking about your holiday gift list though. I'm talking about a list of cryptocurrencies to add to your portfolio before
9 Reasons the Stock Market Could Crash in the Next 3 Months
When taken as a whole, it's been another great year for the stock market. Through Wednesday, Dec. 1, the benchmark S&P 500 (SNPINDEX: ^GSPC) was up 20% on a year-to-date basis. Considering that the
Aspiring Millionaire Investor? This Is a Better Bet Than Shiba Inu
If you're hoping to become a millionaire, investing in a speculative cryptocurrency like Shiba Inu (CRYPTO: SHIB) might seem like a fast-track way to get there.
The meme-based cryptocurrency was
New to the Stock Market? 3 Investments You Can't Go Wrong With.
Getting started as an investor can be a bit intimidating. Everything moves quickly these days, and so many people seem to have a better understanding of how things work. It's easy to justify staying
Is Vertex Pharmaceuticals Stock a Buy Now?
Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) spiked recently in response to good news for an experimental new drug. The past year has been marked by one development setback after another, but